The Discounted Cash Flow (DCF) valuation of Albireo Pharma Inc (ALBO) is (51.63) USD. With the latest stock price at 44.15 USD, the upside of Albireo Pharma Inc based on DCF is -216.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 9.4% | 8.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (126.84) - (30.25) | (51.63) |
| Upside | -387.3% - -168.5% | -216.9% |